Terumo To Sell Home Oxygen Business To Japan's Air Water
This article was originally published in PharmAsia News
Terumo plans to sell its home oxygen business to Air Water, a Japanese producer of industrial and medical oxygen, in an undisclosed deal estimated to be worth $22.6 million.
You may also be interested in...
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.
Early Research Suggests Wearables Can Spot Early Signs Of COVID-19; Fitbit Receives $2.5m Army Award
A consortium of researchers, including Fitbit, are developing algorithms to spot COVID-19 before people become ill.